A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2004
12/01/2004	EP1480961A1 Glutaminyl based dpiv inhibitors
12/01/2004	EP1480946A2 A hydroxamic acid thrombospondin peptide analog that inhibits aggrecanase activity
12/01/2004	EP1480691A2 Agglomerated particles for aerosol drug delivery
12/01/2004	EP1480682A1 Coupling proteins to a modified polysaccharide
12/01/2004	EP1480674A1 Treatment of central nervous system damage
12/01/2004	EP1480670A2 Cg3842 homologous proteins involved in the regulation of energy homeostasis
12/01/2004	EP1480669A1 Use of the insulin-like-growth factor i splice variant mgf for the prevention of myocardial damage
12/01/2004	EP1480668A1 Compositions and methods for promoting lipid mobilization, glycogen mobilization,or both, in humans
12/01/2004	EP1480667A1 Compositions comprising pulmonary surfactants and a polymyxin having improved surface properties
12/01/2004	EP1480665A2 Peptides for recognition and targeting of glial cell tumors
12/01/2004	EP1480655A2 Dna demethylase antisense and chemotherapy combination
12/01/2004	EP1480648A1 Anti-viral compounds
12/01/2004	EP1480646A1 Anti-infective agents and/or immunomodulators used for preventive therapy following an acute cerebrovascular accident
12/01/2004	EP1480628A1 Use of sodium/hydrogen exchange inhibitors for the treatment of thrombotic and inflammatory diseases
12/01/2004	EP1480626A1 Ambroxol for treating painful conditions in the mouth and pharyngeal cavity
12/01/2004	EP1480621A1 Ph-sensitive cationic lipids, and liposomes and nanocapsules containing the same
12/01/2004	EP1480618A1 Sustained release drug formulations containing a carrier peptide
12/01/2004	EP1480614A2 Emulsion containing hydrophobic nanodrops with bound hemoglobin molecules in a hydrophilic phase as a blood substitute
12/01/2004	EP1480598A2 Manipulation of cytokine levels using cd83 gene products
12/01/2004	EP1480526A2 Method for manufacturing beads containing exogenous soy protein
12/01/2004	EP1480525A2 Novel soy protein products
12/01/2004	EP1379139A4 The use of ecm degrading enzymes for the improvement of cell transplantation
12/01/2004	EP1246625B1 Uses and compositions of nitrate esters for providing sedation
12/01/2004	EP1189631B1 Neurodegenerative disorder related gene
12/01/2004	EP1183040B1 Therapeutic use of an inhibitor of a hedgehog signalling pathway
12/01/2004	EP1176975A4 Pharmacokinetic and pharmacodynamic modeling of erythropoietin administration
12/01/2004	EP1176199B1 Tumor suppressor gene
12/01/2004	EP1173197B1 Metabolic intervention with glp-1 to improve the function of ischemic and reperfused tissue
12/01/2004	EP1173191A4 Novel antiangiogenic peptide agents and their therapeutic and diagnostic use
12/01/2004	EP1139784B1 Food-induced antisecretory proteins in egg yolk
12/01/2004	EP1121449A4 Delivery system for porcine somatotropin
12/01/2004	EP1119611A4 Method for the treatment of chemonucleolysis
12/01/2004	EP1117388A4 Antioxidant gel for gingival conditions
12/01/2004	EP1082422B1 Polypeptides from creb binding protein and related protein p300 for use in transcriptional regulation
12/01/2004	EP1073745B1 Immunization against and treatment for infection by h. pylori
12/01/2004	EP1012180B1 Hepatitis c inhibitor peptide analogues
12/01/2004	EP0981365B1 Leptin as an inhibitor of tumor cell proliferation
12/01/2004	EP0917571B1 Agouti-related gene
12/01/2004	EP0912611B9 Human monoclonal antibodies to the hepatitis b surface antigen
12/01/2004	EP0909320A4 CHEMOKINE beta-15
12/01/2004	EP0590048B1 A process for preparing therapeutic fragments of von willebrand factor
12/01/2004	EP0551401B2 Methods and compositions for genetic therapy and potentiation of anti-tumor immunity
12/01/2004	CN1551923A 皮肤处理 Skin treatment
12/01/2004	CN1551914A FAD4, FAD5, FAD5-2 and FAD6, novel fatty acid desaturase family members and uses thereof
12/01/2004	CN1551888A Modified human growth hormone
12/01/2004	CN1551887A Novel depsipeptides and process for preparing same
12/01/2004	CN1551886A Specific human antibodies for selective cancer therapy
12/01/2004	CN1551789A Single dose aromatase inhibitor for treating infertility
12/01/2004	CN1551785A Sustained release of microcrystalline peptide suspensions
12/01/2004	CN1551782A Chimeric flavivirus vectors
12/01/2004	CN1551780A Oxynthomodulin for preventing or treating excess weight
12/01/2004	CN1551779A Osteogenis oligopeptide as blood-formation stimulation articles
12/01/2004	CN1551770A Sustained release formulations of oxymorphone
12/01/2004	CN1551760A Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis
12/01/2004	CN1550501A Oligopolynucleotide of inhibiting activity of necrosin in human tumor
12/01/2004	CN1550235A Use of heparin-binding antagonists in the inhibition of bradykinin release
12/01/2004	CN1550232A Use of heterocyclic amide in production of autoimmune diseases inhibitors
12/01/2004	CN1550231A Method and compositions for administering taxanes orally to human patients
12/01/2004	CN1550160A Alkaline mineral matter solution ,its preparation method and food for preventing osteoporosis using it
12/01/2004	CN1177934C Adneovirus-mediated intratumoral delivery of angiogenesis antagonist for treatment of tumors
12/01/2004	CN1177862C Human NIP2 associated protein and coding sequence and application thereof
12/01/2004	CN1177861C Macrocylic peptides active against the hepatitis V virus
12/01/2004	CN1177616C Recombinant antibodies specific for beta-amyloid ends, DNA encoding and methods of use thereof
12/01/2004	CN1177615C Arteriovenous and venous graft treatment methods and compsns.
12/01/2004	CN1177614C Slow releasing composition
12/01/2004	CN1177613C Chemokine receptor antagonist and ocyclosporin in combined therapy
12/01/2004	CN1177612C Composition for sustained release of non-aggregated erythropoietin
12/01/2004	CN1177611C Preventive and therapeutic compsns. for drug induced nephropathy and hepatitis
12/01/2004	CN1177610C Pharmaceutical composition for immunomodulation based on peptides and adjuvants
12/01/2004	CN1177595C Use of composition for increasing insulin activity
12/01/2004	CN1177583C Formulations for parenteral use of estramustine phosphate with improved pharmacological properties
12/01/2004	CN1177581C Aqueous aerosol preparations containing biologically active macromolecules and method for producing the corresponding aerosols
11/2004
11/30/2004	US6825337 Antisense modulation of PLML expression
11/30/2004	US6825334 Interleukin-2 (il-2) for drugs/drug screening; genetic engineering; mitogen-activated protein kinases (map-k)
11/30/2004	US6825333 EGFH2 genes and gene products
11/30/2004	US6825329 Human PEM as a target for birth control and treatment of Alzheimer's disease
11/30/2004	US6825326 Antibody which specifically binds to prostate stem cell antigen on surface of carcinoma cells and is internalized within carcinoma cells to which it binds
11/30/2004	US6825324 Antibodies to receptor protein tyrosine kinases
11/30/2004	US6825323 For multiple external/internal wounds; kits
11/30/2004	US6825322 Human N-methyl-D-aspartate receptor subunits, nucleic acids encoding same and uses therefor
11/30/2004	US6825321 For breeding cold-avoidance plants; treatment of diabetes metllitus/obesity; development of thermogenic bio-materials
11/30/2004	US6825320 For diagnosis/prevention/treatment of tumors/cancer
11/30/2004	US6825319 Synthetic peptides and pharmaceutical compositions comprising them for diagnosis and treatment of anti-phospholipid syndrome
11/30/2004	US6825318 Vaccine for obesity therapy; hybrid polypeptides
11/30/2004	US6825317 Histone deacetylase inhibitor, a major histocompatibility complex class-i molecule expression-promoting agent and anticancer agents
11/30/2004	US6825224 Prodrugs of carbamate inhibitors of IMPDH
11/30/2004	US6825206 Treatment of leukemia, solid tumors and brain glioma in mammals using the conjugates
11/30/2004	US6825203 Topical anesthetic/opioid formulations and uses thereof
11/30/2004	US6825200 Substituted dipeptides having nos inhibiting activity
11/30/2004	US6825178 Discovery that p. aeruginosa binds to the cystic fibrosis transmembrane conductance regulator (cftr)
11/30/2004	US6825174 Mixture of surfactant and nucleic acids
11/30/2004	US6825168 Antithrombin protein and DNA sequences from black fly
11/30/2004	US6825167 Targeting moiety facilitates the interaction and/or binding of the linked antiangiogenic moiety to endothelial cells
11/30/2004	US6825166 Molecular conjugates for use in treatment of cancer
11/30/2004	US6825165 Betacellulin modification
11/30/2004	US6825164 Method to increase cerebral blood flow in amyloid angiopathy
11/30/2004	US6825037 Recombinant transferrins, transferrin half-molecules and mutants thereof
11/30/2004	US6825033 Mutated cyclin G1 protein
11/30/2004	US6825031 Spraying into a hot gas stream an aqueous mixture of the material and a carrier substance which is water-soluble or water-swellable, thereby drying the mixture to particles which contain the material and the carrier substance
11/30/2004	US6825030 Nucleotide sequences coding enzymatic polypeptide for use in generation of lysine for foods, medicines and animal nutrients

1 ... 1526 1527 1528 1529 1530 1531 1532 1533 1534 1535 1536 1537 1538 1539 1540 1541 1542 1543 1544 1545 1546 ... 3163